Rare cancers pose major challenges for both those affected and those treating them. One reason for this is that the low number of cases makes it difficult to obtain clinical data and to conduct meaningful studies on the effectiveness of a therapy. To make matters worse, it is not profitable for the pharmaceutical industry to develop therapies for rare cancers because the potential market is too small.
On the other hand, there are many children and adults who have a rare cancer. Because, all in all, rare cancers are not as rare as the name suggests. About one in five cancers is a rare cancer, including many forms of blood cancer or bone and soft tissue sarcomas. But cancer of the oesophagus, thyroid, larynx and almost all cancers that occur in children also affect fewer than six in 100,000 people per year and are thus considered rare by definition.
Your support is needed to ensure that research is carried out for people suffering from rare cancers. Every franc you donate is used to fund research projects and global research collaborations on rare cancers.
Many children and adults suffer from rare cancers. These are still insufficiently researched and correspondingly difficult to treat.
Help to ensure that cures become the norm.